Soochow University Researchers Describe Research in Lung Cancer (Inhibition of LNC EBLN3P Enhances Radiation-Induced Mitochondrial Damage in Lung Cancer Cells by Targeting the Keap1/Nrf2/HO-1 Axis).
In: Drug Week, 2023-10-13, S. 1205-1205
serialPeriodical
Zugriff:
The news reporters obtained a quote from the research from Soochow University: "Radiotherapy is an effective modality for treating early-stage lung cancer; however, it cannot completely eradicate certain tumor cells due to their radioresistance. Keywords: Cancer; Drugs and Therapies; Genetics; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Oncology; Radiotherapy EN Cancer Drugs and Therapies Genetics Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Oncology Radiotherapy 1205 1205 1 10/09/23 20231013 NES 231013 2023 OCT 10 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Fresh data on lung cancer are presented in a new report. [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Soochow University Researchers Describe Research in Lung Cancer (Inhibition of LNC EBLN3P Enhances Radiation-Induced Mitochondrial Damage in Lung Cancer Cells by Targeting the Keap1/Nrf2/HO-1 Axis).
|
---|---|
Zeitschrift: | Drug Week, 2023-10-13, S. 1205-1205 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Sonstiges: |
|